(Q22252410)
Statements
O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember™ arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks (English)
0 references
July 2008
0 references
4
0 references
4
0 references
T167
0 references